Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Qianqian Zhu, Lori Shepherd, Kathryn L. Lunetta, Song Yao, Qian Liu, Qiang Hu, Stephen A. Haddad A. Haddad, Lara Sucheston-Campbell, Jeannette T. Bensen, Elisa V. Bandera, Lynn Rosenberg, Song Liu, Christopher A. Haiman, Andrew F. Olshan, Julie R. Palmer, Christine B. Ambrosone
Published Nov 4, 2016 · Vol. 7, No. 50 · pp. 83160-83176
Karolina Gołąb, Randall Grose, Piotr Trzonkowski, Amittha Wickrema, Martin Tibudan, Natalia Marek-Trzonkowska, Sabrina Matosz, Julia Solomina, Diane Ostrega, J. Michael Millis, Piotr Witkowski
Published Nov 4, 2016 · Vol. 7, No. 48 · pp. 79474-79484
Christian B. Schiller, Todd A. Braciak, Nadja C. Fenn, Ursula J. E. Seidel, Claudia C. Roskopf, Sarah Wildenhain, Annemarie Honegger, Ingo A. Schubert, Alexandra Schele, Kerstin Lämmermann, Georg H. Fey, Uwe Jacob, Peter Lang, Karl-Peter Hopfner, Fuat S. Oduncu
Published Nov 4, 2016 · Vol. 7, No. 50 · pp. 83392-83408
